Knowledge empowers better conversations and informed decisions. 💙
🔗 Watch now: www.youtube.com/watch?v=rBX4...

#LungCancer #NSCLC #CancerEducation #TargetedTherapy #OncologyUpdates #PatientEducation

Bone cancer develops when abnormal cells start growing rapidly inside a bone, forming a tumor that damages normal bone tissue.

#BoneCancer #HealthAwareness #MedicalFacts #CancerResearch #OncologyUpdates

🔗 Read more: bit.ly/ONCOnews24N-1

#ONCOnews #OncoAlert #OncEd #FDAApproval #BladderCancer #MIBC #OncologyUpdates #Immunotherapy

#ONCOnews #OncoAlert #OncEd #ESMO2025 #LungCancer #NSCLC #OncologyUpdates

🔗 Read more: bit.ly/ONCOnews20O-5

#ONCOnews #OncoAlert #OncEd #ESMO2025 #Oncology #MetastaticCRC #Phase3Trial #OncologyUpdates

✨Inspiring conversations & new connections at #ESMO25! A big thank you to everyone who visited our booth.

Excited for more learning, networking, and innovation on Day 2!

#ONCOassist #OncoAlert #myESMOStory #ESMO2025 #OncologyUpdates #MedicalConference #Berlin #Germany #OncTwitter

#OncologyUpdates
#CancerResearch
#PrecisionMedicine
#ADC
#AccessToCare
#HemOnc
#ONCOassist
#OncoAlert

Synapse: Your Connection to our MSK Authors
Meet: Anna F Piotrowski
Research Focus: Neurology; Assistant Attending

synapse.mskcc.org/synapse/work...

#Ibrutinib #CNSLymphoma #TargetedTherapy #PhaseIITrial #BloodCancer #OncologyUpdates #CancerTreatment #ClinicalTrials #CancerResearch

The Lancet Commission on hepatocellular carcinoma Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancers will nearly double, from 0·87 million in 2022 to 1·52 mil...

The Lancet Commission on hepatocellular carcinoma

thelancet.com/commissions-...

#HepatocellularCarcinoma #LiverCancer #LiverHealth
#CancerResearch #GlobalHealth #TheLancet #LancetCommission #MedicalResearch #OncologyUpdates #CancerAwareness

A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

New waves in kidney cancer treatment! Dr Michael Serzan shares expert insights on breakthrough therapies for early-stage kidney cancer, fresh from the 2025 ASCO Meeting. Promising days for patients. #KidneyCancer #ASCO2025 #CancerTreatment #TCSC #OncologyUpdates

www.curetoday.com/view/a-new-t...

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma - Blood Cancer Journal Blood Cancer Journal - CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Featured today by @MSKLibrary: CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma dx.doi.org/10.1038/s414...

#CAR_TCellTherapy #LargeBCellLymphoma #ExtranodalDisease #LymphomaResearch #Immunotherapy #OncologyUpdates #CancerTreatment #CancerResearch

FDA approval of a targeted doublet marks a shift in treatment options for recurrent low-grade serous ovarian cancer with KRAS mutation. #OncologyUpdates #TargetedTherapy
🔗 ascopost.com/news/may-202...

#CancerSupport #Biomarkers #OncologyUpdates #CancerBreakthroughs #HematologyNews #MedicalOncology #BloodDisorders #CancerInnovation #SurvivorStories #PatientAdvocacy

Kidney cancer at ESMO 2024: CONTACT-03, TiNivo-2 and SUNNIFORECAST - VJOncology Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla, Santander, Spain, comments on recent kidney cancer research presented at the...

#KidneyCancerAwarenessWeek 🌍 🗞️

Dr. Ignacio Duran, Hospital Universitario Marques de Valdecilla, shares insights from key #kidneycancer studies presented at the ESMO 2024 Congress💡🎥

👉 https://buff.ly/42gQE9Y

#ESMO2024 #KidneyCancerResearch #OncologyUpdates #CheckpointInhibitors

📰 Stay Updated with ONCOnews! 📰
Discover over 40+ oncology articles from the past week, all curated to keep you at the forefront of oncology advancements. 🌟

💻📱 Access it now on the ONCOassist buff.ly/4jojbAn !

👉 Don’t miss out—check it out today!

#ONCOnews #OncologyUpdates #ONCOassist #ONCOalert

It has been a busy week - Easily catch up with ONCOnews on @ONCOassist

Explore over 30 oncology articles from the past week.

Access it now: https://buff.ly/4jojbAn !

#ONCOnews #OncologyUpdates #ONCOassist #ONCOalert

📰 Stay Updated with ONCOnews! 📰
Discover over 30+ oncology articles from the past week, all curated to keep you at the forefront of oncology advancements. 🌟

💻📱 Access it now on the ONCOassist buff.ly/4jojbAn !

👉 Don’t miss out—check it out today!

#ONCOnews #OncologyUpdates #ONCOassist #ONCOalert

#MedicalCollaboration #GlobalHealthCare #OncologyCare #CancerResearch #HealthcareInnovation #MedicalLeadership #EducationInMedicine #OncologyUpdates #HealthEquityMatters #OncologyResearch #CancerTreatment #MedicalBreakthroughs #GlobalHealthInitiative

IBRANCE® boosts survival by 15+ months for HR+/HER2+ metastatic breast cancer patients in a new study. A huge step forward! #BreastCancer #CancerResearch #IBRANCE #Pfizer #HealthNews #Breakthrough #OncologyUpdates #BreastCancer #Cancer #Tumor #CancerResearch #HealthBreakthrough #MedicalNews #Pfizer